B

Brain+ A/S
CSE:BRAINP

Watchlist Manager
Brain+ A/S
CSE:BRAINP
Watchlist
Price: 0.0092 DKK -6.12% Market Closed
Market Cap: 10.4m DKK

Profitability Summary

Brain+ A/S's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Brain+ A/S

Revenue
2.5m DKK
Cost of Revenue
-3.5m DKK
Gross Profit
-1m DKK
Operating Expenses
-10.6m DKK
Operating Income
-11.7m DKK
Other Expenses
-384.9k DKK
Net Income
-12m DKK

Margins Comparison
Brain+ A/S Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
DK
Brain+ A/S
CSE:BRAINP
10.4m DKK
-43%
-473%
-489%
US
Veeva Systems Inc
NYSE:VEEV
36.7B USD
76%
29%
28%
US
Cerner Corp
LSE:0R00
31.3B USD
83%
13%
10%
AU
Pro Medicus Ltd
ASX:PME
24.4B AUD
100%
75%
52%
JP
M3 Inc
TSE:2413
1.4T JPY
51%
20%
14%
US
Doximity Inc
NYSE:DOCS
8.5B USD
90%
40%
41%
US
Waystar Holding Corp
NASDAQ:WAY
5.7B USD
68%
23%
11%
SE
Sectra AB
STO:SECT B
48.7B SEK
54%
-14%
29%
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
298.5B INR
100%
25%
18%
US
Inspire Medical Systems Inc
NYSE:INSP
2.8B USD
85%
4%
5%
CN
Winning Health Technology Group Co Ltd
SZSE:300253
19.7B CNY
34%
-7%
-14%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Brain+ A/S Competitors

Country Company Market Cap ROE ROA ROCE ROIC
DK
Brain+ A/S
CSE:BRAINP
10.4m DKK
-103%
-35%
-39%
-35%
US
Veeva Systems Inc
NYSE:VEEV
36.7B USD
14%
12%
14%
49%
US
Cerner Corp
LSE:0R00
31.3B USD
14%
8%
12%
10%
AU
Pro Medicus Ltd
ASX:PME
24.4B AUD
52%
39%
64%
101%
JP
M3 Inc
TSE:2413
1.4T JPY
13%
9%
14%
14%
US
Doximity Inc
NYSE:DOCS
8.5B USD
25%
21%
23%
64%
US
Waystar Holding Corp
NASDAQ:WAY
5.7B USD
4%
2%
5%
4%
SE
Sectra AB
STO:SECT B
48.7B SEK
39%
19%
-18%
-10%
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
298.5B INR N/A N/A N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
2.8B USD
7%
6%
5%
8%
CN
Winning Health Technology Group Co Ltd
SZSE:300253
19.7B CNY
-5%
-4%
-2%
-2%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less